IRIS
VOGRIG, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 900
EU - Europa 391
AS - Asia 130
AF - Africa 23
OC - Oceania 1
SA - Sud America 1
Totale 1.446
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 894
IT - Italia 232
IE - Irlanda 70
IN - India 30
CN - Cina 28
UA - Ucraina 27
TG - Togo 23
DE - Germania 17
SG - Singapore 17
VN - Vietnam 17
TR - Turchia 12
FI - Finlandia 10
SE - Svezia 10
HK - Hong Kong 8
CA - Canada 6
JP - Giappone 5
NL - Olanda 5
GB - Regno Unito 4
PT - Portogallo 4
CZ - Repubblica Ceca 3
FR - Francia 3
BE - Belgio 2
ID - Indonesia 2
KR - Corea 2
PH - Filippine 2
PL - Polonia 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
TW - Taiwan 2
AU - Australia 1
CL - Cile 1
IR - Iran 1
KZ - Kazakistan 1
MY - Malesia 1
Totale 1.446
Salva come PNG Salva come JPEG
Città #
Fairfield 136
Chandler 75
Ashburn 72
Trieste 71
Dublin 70
Woodbridge 63
Seattle 54
Houston 49
Wilmington 45
Cambridge 41
Ogden 29
Venezia 24
Lomé 23
Dearborn 22
Princeton 20
Ann Arbor 19
Dong Ket 17
Hyderabad 16
Milan 16
Tavagnacco 16
Singapore 14
Udine 14
Jacksonville 12
Redmond 12
Beijing 11
Hong Kong 8
Izmir 8
Lappeenranta 8
San Diego 8
Boardman 6
Norwalk 6
Bologna 5
Codroipo 5
New Delhi 5
Nove 5
Amsterdam 4
Beppu 4
Lisbon 4
Zhengzhou 4
Brno 3
Buffalo 3
Cedar Knolls 3
Des Moines 3
Los Angeles 3
Pune 3
Rochester 3
Salt Lake City 3
Ankara 2
Augusta 2
Brussels 2
Chions 2
Frankfurt am Main 2
Gdynia 2
Helsinki 2
Istanbul 2
Kunming 2
Leawood 2
London 2
Munich 2
New York 2
Novate Milanese 2
Ortona 2
Porcia 2
Riyadh 2
Saint Paul 2
Seoul 2
Silea 2
Toronto 2
Treviso 2
Turin 2
Venice 2
Verona 2
Xi'an 2
Andover 1
Ardabil 1
Brescia 1
Camponogara 1
Chennai 1
Chicago 1
Columbia 1
Garbagnate Milanese 1
Genova 1
Gifu 1
Groningen 1
Guangzhou 1
Hanover 1
Hefei 1
Jakarta 1
Kelowna 1
Lapu-Lapu City 1
Lyon 1
Montreal 1
Moreno Valley 1
Mumbai 1
Musile di Piave 1
Nanjing 1
New Orleans 1
Nuremberg 1
Ottawa 1
Palembang 1
Totale 1.124
Salva come PNG Salva come JPEG
Nome #
Epidemiology of autoimmune versus infectious encephalitis 125
Tacrolimus-induced severe headache associated with diffuse leukoencephalopathy: Evidence for an immune-mediated pathogenesis 108
Peculiar EEG signatures, ictal drinking and long-term follow-up in anti-LGI1 encephalitis 106
Effect of thymectomy on refractory autoimmune status epilepticus 101
Seizure specificities in patients with antibody-mediated autoimmune encephalitis 84
Epidemiology of paraneoplastic neurological syndromes: a population-based study 81
Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario 68
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature 66
Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features 62
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up 41
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome 35
Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain–Barré syndrome detected in Europe in the COVID-19 era 35
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination 35
Response to Letter to the Editor on the article “Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination” 29
Stroke in patients with SARS-CoV-2 infection: case series 26
Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research 26
Reader Response: Prolonged Unconsciousness Following Severe COVID-19 25
Eating reflex epilepsy of presumed autoimmune etiology after SARS-CoV-2 vaccination 21
Unclear association between COVID-19 and Guillain-Barré syndrome 21
Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review 20
Stroke in patients with COVID-19: Clinical and neuroimaging characteristics 19
Movement disorders in oncology: From clinical features to biomarkers 18
Efficacy of Perampanel in Refractory and Super-Refractory Status Epilepticus with Suspected Inflammatory Etiology: A Case Series 18
Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic Features 17
Paraneoplastic encephalitis: clinically based approach on diagnosis and management 17
Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA) 16
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 15
Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome 14
Sudden unexpected death in epilepsy and ictal asystole in patients with autoimmune encephalitis: a systematic review 14
Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses 14
Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis 14
Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases 14
Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis 13
Diagnosis of autoimmune encephalitides: An update 13
Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors 12
Glial Fibrillary Acidic Protein Autoimmunity: A French Cohort Study 12
Glioblastoma as differential diagnosis of autoimmune encephalitis 11
Immunomodulation in the acute phase of autoimmune encephalitis 11
Central nervous system adverse events of immune checkpoint inhibitors 11
Role of LGI1 protein in synaptic transmission: From physiology to pathology 11
Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis 11
Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence? 10
How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update 10
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors 10
Epileptic phenotypes in autoimmune encephalitis: From acute symptomatic seizures to autoimmune-associated epilepsy 10
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience 10
Prognosis of status epilepticus in adults: recent advances and future directions 8
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis 8
Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features 8
SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients 8
Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis 8
Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis: Clues for Diagnosis 8
SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques 8
Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review 8
Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors 8
Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment 8
NRAS Q61K mutated diffuse leptomeningeal melanomatosis in an adult patient with a brief review of the so-called “forme fruste” of neurocutaneous melanosis 8
Back to the future: encephalitis lethargica as an autoimmune disorder? 8
A systematic study of stereotypy in epileptic seizures versus psychogenic seizure-like events 8
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity 7
Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis 7
Associations between HLA and autoimmune neurological diseases with autoantibodies 7
Value of Onconeural Antibodies in Checkpoint Inhibitor-Related Toxicities 7
Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors 7
Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies 7
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians 7
Post-acute anti-NMDAR encephalitis mirrors schizophrenia 7
Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes 7
18F-FDG PET brain findings in disease-discordant monozygotic mosaic twins with Cri du Chat (5p-) syndrome 7
Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France 7
Adenovirus COVID-19 Vaccines and Guillain–Barré Syndrome with Facial Paralysis 7
Nystagmus and lower extremity hyperalgesia after colectomy 7
Editorial: Neuroglial antibodies: From clinical associations to pathophysiological investigations 6
Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis 6
Central nervous system complications associated with immune checkpoint inhibitors 6
Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies 6
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes 6
Neuroimmune disorders in COVID-19 6
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma 6
Different Genetic Signatures of Small-Cell Lung Cancer Characterize Anti-GABABR and Anti-Hu Paraneoplastic Neurological Syndromes 6
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration 6
Predictors and Clinical Characteristics of Relapses in LGI1-Antibody Encephalitis 5
Bornavirus associated with fatal human encephalitis 5
Probable dysimmune epilepsia partialis continua manifesting as epileptic moving toes syndrome: electroclinical features of a challenging case 5
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition 5
Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study 5
Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study 5
Proceedings of the “International Congress on Structural Epilepsy & Symptomatic Seizures” (STESS, Gothenburg, Sweden, 29–31 March 2023) 5
Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review 5
Primary DQ effect in the association between HLA and neurological syndromes with anti-GAD65 antibodies 5
Spinal arachnoid cyst as a cause of isolated, progressive, bilateral C5-C6 radiculopathy 4
Postencephalitic epilepsy in children and adults: Etiology matters 4
Intra-carotid self-injection of alprazolam: an unusual cause of unilateral multiembolic stroke 4
Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies 3
Totale 1.769
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.218
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020336 14 9 7 46 37 46 49 38 39 31 8 12
2020/2021255 8 22 11 20 12 24 17 23 46 14 25 33
2021/2022183 9 18 37 6 2 0 13 4 3 20 48 23
2022/2023528 20 18 3 19 176 179 4 8 31 6 17 47
2023/2024343 28 22 5 24 40 18 9 31 44 57 29 36
2024/202529 29 0 0 0 0 0 0 0 0 0 0 0
Totale 1.769